Vaccine

9-valent HPV Vaccine (HPV 9-in-1 Vaccine)

Men and women of any age or sexual orientation can contract the Human Papillomavirus (HPV). Vaccination effectively prevents cervical, vaginal, vulvar, and oropharyngeal cancers, as well as genital warts (condyloma acuminata), reducing the risk of developing cancer and related diseases.

 

Herpes Zoster (Shingles) Vaccine

“Shingles” is medically known as Herpes Zoster, a condition caused by the varicella-zoster virus (the virus responsible for chickenpox), for which there is currently no cure. Patients develop a painful, band-like rash with blisters. After chickenpox heals, the virus remains dormant in the nervous system and may reactivate later to cause shingles. Anyone who has had chickenpox is at risk of developing shingles.

 

13-valent Pneumococcal Conjugate Vaccine (PCV13)

This is currently the pneumococcal vaccine offering the highest protection for infants and young children. The 13-valent vaccine includes coverage for 3 additional serotypes to prevent invasive pneumococcal diseases. Pneumococcal bacteria spread through droplets or respiratory secretions. With over 90 serotypes identified, the bacteria can cause severe illnesses, including pneumonia, meningitis, and otitis media (middle ear infection).

 

Hepatitis B Vaccine

Hepatitis B is a disease that affects the liver, and chronic adult carriers are relatively common in Hong Kong. Chronic infection can lead to cirrhosis or liver cancer. Transmission mainly occurs through contact with blood or body fluids, sexual contact, and mother-to-child transmission during childbirth. If a pregnant woman is a Hepatitis B carrier, administering Hepatitis B Immunoglobulin (HBIG) to the newborn at birth, followed by timely Hepatitis B vaccination, significantly reduces the baby’s risk of infection.

 

Influenza Vaccine

Over the past five years, winter influenza outbreaks have been severe, with an increasing trend in critical cases requiring intensive care unit (ICU) admission or resulting in death. Annual influenza vaccination is recognized as an effective preventive measure. Getting vaccinated ahead of the seasonal flu period helps protect children and vulnerable elderly individuals from infection.

Initial symptoms of influenza closely resemble those of a common cold (e.g., sneezing, coughing, sore throat, and fatigue), making early distinction difficult. However, contracting seasonal flu and missing the optimal treatment window can lead to severe complications or death.

 

Recommended Groups for Influenza Vaccination

  • Pregnant women
  • All individuals aged 6 months or older
  • High-risk groups (including individuals with chronic respiratory, cardiac, renal, metabolic, or haematological conditions)
  • Children under 9 years old who have never received a flu vaccine require 2 doses, administered at least 4 weeks apart
  • Individuals aged 9 or above, or those under 9 who have previously received a flu vaccine, require only 1 dose
  • Children under 9 years old who have previously been vaccinated must present their original vaccination record book

 

Individuals Not Recommended for Influenza Vaccination

  • Infants under 6 months of age
  • Individuals running a fever or currently taking antibiotics on the day of vaccination
  • Individuals with a severe allergic reaction to eggs, neomycin, or gentamicin
  • Individuals who have experienced a severe allergic reaction to any vaccine component or to a previous dose of any influenza vaccine

 

Infant & Child Vaccines